CTRI Number |
CTRI/2023/08/056608 [Registered on: 17/08/2023] Trial Registered Prospectively |
Last Modified On: |
13/08/2023 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Ayurveda |
Study Design |
Randomized, Parallel Group, Placebo Controlled Trial |
Public Title of Study
|
To see the effect of Chakshushya Basti followed by Triphaladi Ghrita Aschyotana and Triphalayasadi Yoga orally in Timira (Simple Myopia). |
Scientific Title of Study
|
Clinical evaluation of Chakshushya Basti followed by Triphaladi Ghrita Aschyotana and Triphalayasadi Yoga orally in Timira (Simple Myopia) |
Trial Acronym |
NIL |
Secondary IDs if Any
|
Secondary ID |
Identifier |
nil |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Jasmeen Saini |
Designation |
PG Scholar |
Affiliation |
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan |
Address |
OPD 1, Department of Shalakya-Tantra, Patanjali ayurved hospital,
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Phase
1, Roorkee road, Haridwar, Uttarakhand, India 249405
Hardwar UTTARANCHAL 249405 India |
Phone |
9872755662 |
Fax |
|
Email |
jspabla20@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Prof Anil Verma |
Designation |
HOD and Professor |
Affiliation |
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan |
Address |
OPD 1, Department of Shalakya-Tantra, Patanjali ayurved hospital,
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Phase
1, Roorkee road, Haridwar, Uttarakhand, India 249405
Hardwar UTTARANCHAL 249405 India |
Phone |
9897298775 |
Fax |
|
Email |
dranilverma11@gmail.com |
|
Details of Contact Person Public Query
|
Name |
Jasmeen Saini |
Designation |
PG Scholar |
Affiliation |
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan |
Address |
OPD 1, Department of Shalakya-Tantra, Patanjali ayurved hospital,
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Phase
1, Roorkee road, Haridwar, Uttarakhand, India 249405
Hardwar UTTARANCHAL 249405 India |
Phone |
9872755662 |
Fax |
|
Email |
jspabla20@gmail.com |
|
Source of Monetary or Material Support
|
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar |
|
Primary Sponsor
|
Name |
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan |
Address |
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar, uttarakhand -249405 |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Jasmeen Saini |
Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan |
OPD 1, Patanjali Bhartiya
Ayurvigyan Evam
Anusandhan Sansthan, Phase 1,
Roorkee road
Haridwar, uttarakhand, 249405
Hardwar UTTARANCHAL |
9872755662
jspabla20@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethical Committee, Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition:H521||Myopia. Ayurveda Condition: TIMIRAH, |
|
Intervention / Comparator Agent
|
sno | Intervention/Comparator | Type | Drug-Type | Procedure Name | Details | 1 | Intervention Arm | Drug | Classical | | (1) Medicine Name: triphalayasadi yoga, Reference: Gadanigraha (Shalakyadi – Panchkarmadhikaranto Bhaga), Rasayan Tantra, Aushadhikalpadhikara, Triphala Kalpa. 2/120-123, Route: Oral, Dosage Form: Churna/ Powder, Dose: 500(mg), Frequency: od, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -ghrita, madhu), Additional Information: - | 2 | Intervention Arm | Procedure | - | AScyotanam, आशà¥à¤šà¥à¤¯à¥‹à¤¤à¤¨à¤®à¥ | (Procedure Reference: sushruta samhita, uttartantra , 18/45, Procedure details: aschyotana for 45 days) (1) Medicine Name: triphaladi ghrita, Reference: Ashtanga-hridyam, Uttarsthana, 13/10-11, Route: Ocular, Dosage Form: Bindu/ Drops/ Spray (Karna/ Nasa/ Netra/ Mukha), Dose: 10(drops), Frequency: od, Duration: 45 Days | 3 | Intervention Arm | Procedure | - | bastikarma/vastikarma, बसà¥à¤¤à¤¿à¤•रà¥à¤®/वसà¥à¤¤à¤¿à¤•रà¥à¤® | (Procedure Reference: Ashtanga-hridyam, Kalpasidhisthana, 4/27-28, Procedure details: siddha basti for 8 days)
| 4 | Comparator Arm (Non Ayurveda) | | - | placebo | placebo topically and orally |
|
|
Inclusion Criteria
|
Age From |
8.00 Year(s) |
Age To |
30.00 Year(s) |
Gender |
Both |
Details |
1. Patients with classical symptoms of Timira and simple myopia (up to -6D).
2. Patients between the age group of 8 years to 30 years of either sex.
3. Patients with symptoms like blurring of vision and short-sightedness.
|
|
ExclusionCriteria |
Details |
1. Patients having age less than 8 years and more than 30 years.
2. Patients having high myopia (>6D).
3. Patients suffering from any other eye diseases like corneal xerosis, corneal ulcer, corneal opacity, cataract, diabetic retinopathy, macular degeneration etc. retinal diseases.
4. Patients suffering from other systemic diseases & metabolic disorders.
5. Patients with classical contra-indicatory conditions for Basti. |
|
Method of Generating Random Sequence
|
Computer generated randomization |
Method of Concealment
|
On-site computer system |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
assessment will be made on the basis of subjective & objective criteria.
blood investigation - CBC to exclude any systemic disease, HbA1C to exclude diabetes. |
0, 3 weeks, 8 weeks |
|
Secondary Outcome
|
Outcome |
TimePoints |
assessment will be made on the basis of subjective & objective criteria.
blood investigation - CBC to exclude any systemic disease, HbA1C to exclude diabetes. |
0, 3 weeks, 8 weeks |
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
Phase 2 |
Date of First Enrollment (India)
|
24/08/2023 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="5" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
N/A |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
This study is a Clinical Evaluation of Chakshushya Basti followed by Triphaladi Ghrita Aschyotana and Triphalayasadi Yoga orally in timira (Simple myopia)â€. This will be conducted on 60 patients from OPD/IPD of Shalakya - Tantra Department of Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan, Haridwar. Patients will be divided into two groups - 30 patients will be given Chakshushya Basti followed by Triphaladi Ghrita Aschyotana and Triphalayasadi Yoga orally and 30 patients will be given Placebo topically and orally. 1st follow up after 15 days of basti treatment and 2nd follow up at the completion of treatment. Assessment will be done on the basis of subjective and objective parameters as discussed earlier.
|